Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

331
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
331
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

2.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.8K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

704
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
704
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

360
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
360
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

347
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
347

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The RASE Technique for Extraction of a Protruding Aorto-Ostial Coronary Stent.

JACC. Case reports·2026
Same author

Efficacy and safety of single antiplatelet therapy with anticoagulation in patients with AMI-cardiogenic shock requiring VA-ECMO.

Perfusion·2026
Same author

Optimal Large-Bore Vascular Access and Closure for Percutaneous Mechanical Circulatory Support in Cardiogenic Shock.

Interventional cardiology clinics·2026
Same author

Outcomes of Prasugrel vs Ticagrelor Following Percutaneous Coronary Intervention for Coronary Artery Disease.

The Canadian journal of cardiology·2026
Same author

Workflow-based Framework to Aid with High-Definition Intravascular Ultrasound-Optimised Coronary Stenting: Introducing IVUS 123 Essentials.

Interventional cardiology (London, England)·2026
Same author

Paclitaxel-Coated Balloon for Treating In-Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE Trial.

Journal of the American Heart Association·2026

相关实验视频

Updated: Jan 13, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.7K

在缺血性左心室功能障碍中进行再血管:一种病理生理学引导的,基于证据的方法.

Matthew Ryan1, Alexander G Truesdell2, Gavin J Murphy3

  • 1School of Cardiovascular and Metabolic Medicine & Sciences, British Heart Foundation Centre of Excellence, King's College London, London, United Kingdom.

JACC. Cardiovascular interventions
|October 28, 2025
PubMed
概括

缺血性左心室功能障碍 (iLVD) 管理正在发展. 本综述阐明了冠状动脉复血管化对心力衰竭患者的好处,并指导了皮肤穿冠状动脉干预 (PCI) 决策.

关键词:
冠状动脉疾病是一种冠状动脉疾病.心脏衰竭是因为心脏衰竭.具有高风险的PCI.缺血性心脏病是一种心脏病.机械循环支持 机械循环支持通过皮肤进行冠状动脉干预.

更多相关视频

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.3K
Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.4K

相关实验视频

Last Updated: Jan 13, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.7K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

4.3K
Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.4K

科学领域:

  • 心脏病学 心脏病学
  • 心脏衰竭研究研究
  • 干预心脏病学 干预心脏病学

背景情况:

  • 缺血性左心室功能障碍 (iLVD) 是心力衰竭的主要原因之一.
  • 与非缺血性心肌病相比,iLVD与较高的死亡率有关.
  • 从历史上看,冠状动脉再血管化是iLVD的标准,但最近的试验挑战了这种做法.

研究的目的:

  • 审查iLVD的病理生理学.
  • 分析随机试验证据关于iLVD冠状动脉再血管化的证据.
  • 在iLVD中定义冠状动脉旁路移植和皮肤冠状动脉干预 (PCI) 的患者选择标准.

主要方法:

  • 关于病理生理学和临床试验的综合文献综述.
  • 对冠状动脉复血管化策略的随机证据的分析.
  • 在iLVD患者中开发PCI的实用指南.

主要成果:

  • 该综述综合了目前对iLVD病理生理学的理解.
  • 最近随机试验的证据被批判性地检查.
  • 为选择受益于再血管化的iLVD患者提供了指导方针.

结论:

  • 对于iLVD的冠状动脉再血管化决定需要仔细的患者选择.
  • 皮肤穿透冠状动脉干预 (PCI) 的规划和执行是详细的.
  • 强调了共享决策和完整的再血管化,并指出了未来的机械循环支持试验.